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Background
Every year over 3.8 million people are dying of diabetes
and its complications. Lifestyle intervention was suggested
to have beneficial effects in preventing and reducing dia-
betes incidence. Especially interventions in patients with
impaired glucose tolerance (IGT), who belong to a high
risk group in developing diabetes, are supposed to be very
effective. According to the evidence heirarchy, a 1a level of
evidence is missing and therefore a systematic review veri-
fying the efficacy of lifestyle intervention is needed.
Materials and methods
Systematic review: The electronic database PubMed,
Embase, Cochrane Central Register of Controlled Trials,
Cochrane Database of Systematic Reviews, and Health
Technology Assessment database were searched. Main
inclusion criteria were randomized controlled trials,
impaired glucose tolerance, lifestyle intervention with con-
trol group and observation time >6 month. Outcome mea-
sures were all diabetes events, as defined by the authors of
each study, all-cause mortality, diabetes mortality, and
quality adjusted life years (QALY). Two independent
reviewers abstracted the found studies by title, abstract
and full-text analysis. Furthermore the reporting quality of
each study was assessed by using the CONSORT criteria
(Consolidated Standards of Reporting Trials) and the
methodological quality by SIGN 50 instrument (Scottish
Intercollegiate Guidelines Network methodology checklist
for randomized controlled trials). The primary outcome
measure was diabetes incidence. Secondary outcome
measures were overall mortality, disease-specific mortality,
quality adjusted life years (QALY), and clinical parameters;
body mass index (BMI), weight change, blood pressure,
blood parameter, smoking, alcohol consumption.
Results
7 trials which included 25 relevant publications were
identified [1-25]. Kappa Cohens for title-analysis were
K=0.77, (CI=0.71-0.83), abstract-analysis K=0.81
(CI=0.64-0.92) and full-text analysis K=0.78 (CI=0.57-
0.98). Overall 5663 patients were analyzed with primary
follow-up time: India (3 yr), Japan (4 yr), Sweden (5 yr),
Da Qing (6 yr), SIM (3 yr), DPP (5 yr), DPS (4 yr) and
drop-out rate ranges from 5% to 28%. Diabetes incidence
ranges from 3% to 46% in the intervention group and
9.3% to 67.7% in the control group. The India study
reported ARR= 16%, RRR= 29% (p=0.018), Japan: ARR=
6.3%, RRR= 65% (p<0.001), Sweden: ARR= 4%, RRR=
25% (p=not significant), Da Qing: ARR= 22%, RRR= 32%
(p<0.05), SLIM: ARR= 20%, RRR= 53% (p=0.025), DPP:
ARR= 15%, RRR= 58% (significant, no p value reported),
and DPS: ARR=12%, RRR= 52% (significant, no p value
reported). Mortality and morbidity were only analyzed in
Da Qing study which showed no statistical differences
(overall mortality: HRR 0.96, CI 0.65-1.41, CVD-mortal-
ity: HRR 0.83; CI 0.48-1.40, CVD event: HRR 0.98; CI
0.71-1.37).
Conclusions
Under consideration of heterogeneity in lifestyle inter-
ventions and follow up time of the included studies, this
systematic review illustrated that lifestyle intervention
can have a beneficial effect on the incidecne of diabetes
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several studies found the effect of lifestyle intervention
decreased after intervention was terminated. Develop-
ment of standardized lifestyle intervention program is
strongly needed and further long term intervention trials
using this program are crucial in evidencing the long
term efficacy.
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